1. Home
  2. JZXN vs VVOS Comparison

JZXN vs VVOS Comparison

Compare JZXN & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JZXN

Jiuzi Holdings Inc.

HOLD

Current Price

$1.50

Market Cap

16.2M

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$1.62

Market Cap

17.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JZXN
VVOS
Founded
2019
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
17.4M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
JZXN
VVOS
Price
$1.50
$1.62
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
5.2M
124.1K
Earning Date
01-01-0001
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.07
EPS
N/A
N/A
Revenue
N/A
$15,031,000.00
Revenue This Year
N/A
$28.86
Revenue Next Year
N/A
$48.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.91
52 Week Low
$0.12
$1.42
52 Week High
$8.50
$7.40

Technical Indicators

Market Signals
Indicator
JZXN
VVOS
Relative Strength Index (RSI) 48.29 44.03
Support Level $1.20 $1.46
Resistance Level $2.79 $1.67
Average True Range (ATR) 0.52 0.13
MACD -0.02 0.02
Stochastic Oscillator 25.56 45.24

Price Performance

Historical Comparison
JZXN
VVOS

About JZXN Jiuzi Holdings Inc.

Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: